YCBD Share Price | cbdMD, Inc. Stock Analysis & Recommendation

Q: How big is cbdMD, Inc.?

Market Cap: As of Jun 18, cbdMD, Inc. has a market capitalization of 7.32 million, categorizing it as a Micro Cap company.Recent Quarterly Performance: For the latest four quarters, cbdMD, Inc. reported net sales of 19.59 million and a net profit of -0.15 million.Balance Sheet Snapshot: As of September 2024, the company reported shareholder's funds of 1.96 million and total assets of 10.58 million.

Q: What does cbdMD, Inc. do?

Overview: cbdMD, Inc. operates in the Pharmaceuticals & Biotechnology industry, focusing on consumer hemp-based cannabidiol (CBD) products.Financial Snapshot: Most recent Net Sales: 5 Million (Quarterly Results - Mar 2025) Most recent Net Profit: 0 Million (Quarterly Results - Mar 2025) Market cap: USD 7.32 Million (Micro Cap)Key Metrics: P/E: NA (Loss Making) Industry P/E: NA Dividend Yield: 0.00% Debt Equity: -1.02 Return on Equity: -119.47% Price to Book: 7.32Contact Details: Address: 8845 Red Oak Blvd, CHARLOTTE NC: 28217-5593 Tel: 1 704 4453060 Website: https://www.cbdmd.com/

Q: Is cbdMD, Inc. overvalued or undervalued?

As of 9 February 2021, cbdMD, Inc. moved from fair to risky, indicating a deterioration in its valuation outlook. The company appears to be overvalued, particularly given its negative financial metrics. The Price to Book Value stands at 8.51, while the EV to EBITDA ratio is 7.49, suggesting that the market is pricing the company at a premium despite its loss-making status. Additionally, the ROE is alarmingly low at -119.47%, highlighting significant inefficiencies in generating returns for shareholders.In comparison to its peers, cbdMD, Inc. has a P/E ratio of -3.7225, which is less favorable than Mannatech, Inc. at -6.5265 and Flora Growth Corp. at -1.0973, both of which also face challenging valuations. The company's stock has significantly underperformed against the S&P 500, with a year-to-date return of -76.01% compared to the index's 12.22%, reinforcing the notion that it is overvalued in the current market environment.

Q: Is cbdMD, Inc. technically bullish or bearish?

As of 2 September 2025, the technical trend for cbdMD, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by conflicting indicators: the MACD is mildly bullish on both weekly and monthly time frames, while Bollinger Bands are bearish on the monthly and mildly bearish on the weekly. The daily moving averages indicate a bearish trend. The KST shows a mildly bullish signal on the weekly but bearish on the monthly, and the OBV is mildly bullish on the weekly with no trend on the monthly.In terms of performance, cbdMD, Inc. has seen a 1-week return of 2.95% compared to the S&P 500's 1.05%, and a 1-month return of 5.82% against the S&P 500's 2.33%. However, year-to-date, the stock is down 76.01%, significantly underperforming the S&P 500, which is up 12.22%.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

308.34 k

Shareholding (Sep 2025)

FII

0.44%

Held by 5 FIIs

DII

98.86%

Held by 1 DIIs

Promoter

0.00%

How big is cbdMD, Inc.?

22-Jun-2025

As of Jun 18, cbdMD, Inc. has a market capitalization of 7.32 million, with net sales of 19.59 million and a net profit of -0.15 million over the last four quarters. As of September 2024, the company reported shareholder's funds of 1.96 million and total assets of 10.58 million.

View full answer

What does cbdMD, Inc. do?

22-Jun-2025

cbdMD, Inc. specializes in consumer hemp-based cannabidiol (CBD) products within the Pharmaceuticals & Biotechnology industry. As of March 2025, it reported net sales of $5 million and has a market cap of $7.32 million.

View full answer

Is cbdMD, Inc. overvalued or undervalued?

20-Sep-2025

As of February 9, 2021, cbdMD, Inc. is considered overvalued with a deteriorating outlook, reflected in its high Price to Book Value of 8.51, negative financial metrics including a P/E ratio of -3.7225, and a significant year-to-date stock decline of -76.01% compared to the S&P 500's 12.22% return.

View full answer

Is cbdMD, Inc. technically bullish or bearish?

20-Sep-2025

As of September 2, 2025, cbdMD, Inc. is in a mildly bearish trend with mixed indicators, showing a 1-week return of 2.95% and a 1-month return of 5.82%, but down 76.01% year-to-date compared to the S&P 500's 12.22% gain.

View full answer

Compare cbdMD, Inc. with Similar Stocks

Enveric Biosciences, Inc.Clever Leaves Holdings, Inc.Qualigen Therapeutics, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 7 Million (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.21

Return on Equity

-29.45%

Price to Book

0.98

Revenue and Profits:

Net Sales:

5 Million

(Quarterly Results - Sep 2025)

Net Profit:

-1 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

11.8%

6 Months

9.33%

1 Year

-80.73%

2 Years

-84.18%

3 Years

184.05%

4 Years

-99.74%

5 Years

-99.94%

cbdMD, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-13.31%

EBIT Growth (5y)

13.76%

EBIT to Interest (avg)

-11.15

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.02

Sales to Capital Employed (avg)

4.48

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

6.79%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

8.51

EV to EBIT

-6.23

EV to EBITDA

7.49

EV to Capital Employed

-7.49

EV to Sales

0.38

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-119.47%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Bullish

Bearish

Dow Theory

No Trend

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Sep 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 3 Schemes (0.7%)

Foreign Institutions

Held by 5 Foreign Institutions (0.44%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 2.17% vs -2.13% in Jun 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 22.22% vs -80.00% in Jun 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4.70",
          "val2": "4.60",
          "chgp": "2.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.30",
          "val2": "-0.50",
          "chgp": "40.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.70",
          "val2": "-0.90",
          "chgp": "22.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-145.30%",
          "val2": "-196.40%",
          "chgp": "5.11%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Sep 2025 is -1.54% vs -19.42% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Sep 2025 is 45.95% vs 83.84% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "19.20",
          "val2": "19.50",
          "chgp": "-1.54%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.40",
          "val2": "-1.40",
          "chgp": "71.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.10",
          "val2": "-0.50",
          "chgp": "120.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2.00",
          "val2": "-3.70",
          "chgp": "45.95%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-112.70%",
          "val2": "-163.70%",
          "chgp": "5.10%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ

Sep'25

Jun'25

Change(%)

Net Sales

4.70

4.60

2.17%

Operating Profit (PBDIT) excl Other Income

-0.30

-0.50

40.00%

Interest

0.00

Exceptional Items

0.00

Consolidate Net Profit

-0.70

-0.90

22.22%

Operating Profit Margin (Excl OI)

-145.30%

-196.40%

5.11%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Sep 2025 is 2.17% vs -2.13% in Jun 2025

Consolidated Net Profit

QoQ Growth in quarter ended Sep 2025 is 22.22% vs -80.00% in Jun 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Sep'25

Sep'25

Sep'24

Change(%)

Net Sales

19.20

19.50

-1.54%

Operating Profit (PBDIT) excl Other Income

-0.40

-1.40

71.43%

Interest

0.00

Exceptional Items

0.10

-0.50

120.00%

Consolidate Net Profit

-2.00

-3.70

45.95%

Operating Profit Margin (Excl OI)

-112.70%

-163.70%

5.10%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Sep 2025 is -1.54% vs -19.42% in Sep 2024

Consolidated Net Profit

YoY Growth in year ended Sep 2025 is 45.95% vs 83.84% in Sep 2024

All Annual Results

Company CV

About cbdMD, Inc.

cbdMD, Inc.

Pharmaceuticals & Biotechnology

cbdMD Inc, formerly Level Brands, Inc., owns and operates consumer hemp-based cannabidiol (CBD) brand, cbdMD. The Company’s products categories include CBD gummies, CBD tinctures, CBD topical, CBD bath bombs, CBD Vape oils and CBD pet products.

Company Coordinates

Company Details

8845 Red Oak Blvd , CHARLOTTE NC : 28217-5593

Tel: 1 704 4453060

https://www.cbdmd.com/

Registrar Details

cbdMD, Inc.

1Day

52 Week

CASH

FII

DII

Promoter

How big is cbdMD, Inc.?

Watch in Real-Time

What does cbdMD, Inc. do?

Is cbdMD, Inc. overvalued or undervalued?

Is cbdMD, Inc. technically bullish or bearish?

Compare cbdMD, Inc. with Similar Stocks

MarketsMojo — Loved in India, Now Global

Dashboard

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Sep 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ

Annual Results Snapshot (Consolidated) - Sep'25

About cbdMD, Inc.

Company Coordinates